Open Your FREE Demat Account Now!

Jupiter Life Line Hospitals Ltd. Share Price

NSE
BSE

NSE : JLHL

BSE : 543980

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹279.75

High

₹329.70

Price Summary

Previous Close ₹317.40
Day's Range ₹279.75 - ₹329.70
Open ₹281.20
52 Week Range ₹233.40 - ₹340.00
Volume 1,87,11,481
Market Cap ₹0.01
Previous Close ₹317.25
Day's Range ₹281.35 - ₹329.50
Open ₹281.35
52 Week Range ₹230.41 - ₹337.90
Volume 7,45,941
Market Cap ₹0.01

Stocks Summary

Trade Value ( ₹ in Lacs) 59,473.22
Market Cap (₹ in Mn) 0.01
Dividend Yield(%) 0.06
Price/Earning (TTM) 55.79
TTM EPS (₹) 5.69
P/E Ratio 43.01
Book Value(₹) 6.38
PAT Margin (%) 12.95
Face Value (₹) 2.00
ROCE(%) 15.70
Trade Value ( ₹ in Lacs) 2,369.48
Market Cap (₹ in Mn) 0.01
Dividend Yield(%) 0.06
Price/Earning (TTM) 55.79
TTM EPS (₹) 5.69
P/E Ratio 43.01
Book Value(₹) 6.38
PAT Margin (%) 12.95
Face Value (₹) 2.00
ROCE(%) 15.70

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 3936.29 10600.65
Expenses N/A N/A
PBT 742.22 2463.44
Operating profit 0.0 0.0
Net profit 574.77 1847.02

Shareholding Pattern

Promoters (% Holding)

40.91%

Mutual funds (% Holding)

13.45%

Non-Institution (% Holding)

34.25%

FI/Banks/Insurance (% Holding)

2.10%

Government (% Holding)

0.00%

FII

9.13%

About Jupiter Life Line Hospitals Ltd.

Founded 2002
Managing Director Ankit Thakker
NSE Symbol JLHL

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,52,298.64 1,885.10 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 2,97,324.81 11,200.00 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,78,727.25 4,698.80 3,672.30 - 3,672.30
Apollo Hospitals Enterprise Ltd. 1,32,138.82 9,190.05 6,696.50 - 6,696.50
Lenskart Solutions Ltd. 1,29,508.26 737.00 0.00 - 0.00
Laurus Labs Ltd. 1,24,001.65 2,295.00 917.95 - 917.95
Zydus Lifesciences Ltd. 1,19,206.70 1,195.05 835.50 - 835.50
Dr. Reddy's Laboratories Ltd. 1,16,144.51 1,390.50 1,101.00 - 1,101.00
Cipla Ltd. 1,14,312.12 1,414.95 1,165.70 - 1,165.70
Mankind Pharma Ltd. 1,09,880.22 2,660.00 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Oct
26
2026
EQUITY Posted on Oct 26th 2026

Jupiter Life Line Hospitals informs about audio link of investor conference call

Pursuant to Regulation 30 and Regulation 46(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jupiter Life Line Hospitals has informed that the Audio Link of the Conference Call held today, Monday, October 26, 2026 at 10:00 AM IST for the quarter and half year ended on September 30, 2026 has been made available on the website of the Company at: - jupiterhospital.com/wp-content/uploads/2026/10/Earnings-Call-Audio-Recording-Quarter-2.mp3.

The above information is a part of company’s filings submitted to BSE.

Read More
Oct
19
2026
EQUITY Posted on Oct 19th 2026

Jupiter Life Line Hospitals informs about updates

Jupiter Life Line Hospitals has informed that the Jupiter Life Line Hospitals Limited (JLHL/Company) has entered into hypothecation agreement with HDFC Bank executed on 18/10/2026 for financing the capital expenditure requirement of the Company. The details as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is attached as ‘Annexure A’. The same will be available on the website of the Company at www.jupiterhospital.com.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
21
2026
EQUITY Posted on Nov 21st 2026

FDC informs about disclosure

Pursuant to the provisions of Regulation 30 read with Part A Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), FDC has informed that the Company has received an Interim Stay Order from the Hon'ble High Court of Bombay Bench at Aurangabad dated November 20, 2026 staying the Directions of Maharashtra Pollution Control Board (MPCB) directing closure of manufacturing operations of the Company’s unit situated at Plot no. B-8, MIDC, Waluj, Chhatrapati Sambhajinagar under the Water (Prevention and Control of Pollution) Act, 1974 and/or the Air (Prevention and Control of Pollution) Act, 1981, and the rules framed thereunder. The Company had already submitted to MPCB its Compliance Reports on their observations. The requisite disclosure as required under Regulation 30 of the SEBI Listing Regulations and SEBI Master Circular Ref. No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is enclosed as Annexure I.

The above information is a part of company’s filings submitted to BSE.

Read More
Nov
21
2026
EQUITY Posted on Nov 21st 2026

Zydus Lifesciences informs about press release

Zydus Lifesciences has informed that it enclosed Newspaper publication of notice for opening of Special Window for transfer and dematerialization of physical securities, published in the Financial Express English and Gujarati Editions, both on November 21, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
21
2026
EQUITY Posted on Nov 21st 2026

3B BlackBio Dx informs about outcome of schedule of analyst meeting

In continuation to earlier letter Ref. No.P-66/2026-27/55 dated 16th November, 2026 respectively, 3B BlackBio Dx has informed that the Company interacted one to one with Fortuna Asset Managers LLP, Delhi on Saturday, 21th November, 2026 at 12:00 hrs India Time. The meeting concluded at 13:00 hrs India Time. The information which is already available in public domain was discussed and no unpublished price sensitive information pertaining to the company was shared with the investor. During this investor meeting, the company reiterated the information shared by it through Investor Presentation of Q2-FY27, which was earlier intimated to the Stock Exchanges vide Ref. No.P66/2026-27/53 dated 13th November, 2026. The company has enclosed the web link of the presentation placed before investors after the declaration of the financial results for the quarter and half year ended 30-09-2026 and the above-mentioned investor. 

The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Jupiter Life Line Hospitals Ltd. ?

The current share price of Jupiter Life Line Hospitals Ltd. is ₹317.40 as of 2026-11-20.

The market capitalisation of Jupiter Life Line Hospitals Ltd. is ₹10,400.41 as of 2026-11-20.

The 1-year return of Jupiter Life Line Hospitals Ltd. is 23.22% as of 2026-11-20.

The P/E ratio of Jupiter Life Line Hospitals Ltd. is 43.01 as of 2026-11-21.

The 52-week high and low of Jupiter Life Line Hospitals Ltd. are ₹340.00 and ₹233.40, respectively, as of 2026-11-20.

The dividend yield of Jupiter Life Line Hospitals Ltd. is 0.063% as of2026-11-20.

You can buy Jupiter Life Line Hospitals Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Jupiter Life Line Hospitals Ltd. is Ankit Thakker.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore